semaglutide for addiction treatment GLP-1 Alcohol Cravings: How Ozempic Helps Quit Drinking Five things to know about
Description
Prolonged and unregulated use could also impact hormonal balance, potentially leading to adverse effects on thyroid function and natural growth hormone production

Changes in social interactions and identity can also contribute to emotional challenges

The Bottom Line Menopause creates a dual problem: hormonal deficiency and metabolic disruption

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that reduces appetite and helps regulate blood sugar, leading to consistent weight loss in most patients

By late 2022, media coverage of GLP-1 weight-loss benefits (widely shared on social media) outpaced supply, prompting an FDA shortage declaration for Ozempic/Wegovy (March 2022)
Sustainable Weight Loss: Studies have shown that patients using semaglutide can achieve substantial weight loss (up to 15% of their body weight over two years), which is maintainable with ongoing treatment
